GlassScriptPhysician profile
Jordan Schmerbauch
NPI 1679195002
$3,481.37
in general payments reported to CMS, 2019-2025
17 companies · $1,355 in 2025
The $1,355 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.01 · 2022: $365 · 2023: $898 · 2024: $847 · 2025: $1,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,100.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $652.70 | 2022-2025 | Wavelight Ex500 Excimer Laser, Clareon Panoptix Pro, Rocklatan |
| Sun Pharmaceutical Industries INC. | $389.44 | 2022-2025 | Cequa, Xelpros |
| Dompe US, INC. | $354.13 | 2023-2025 | Oxervate |
| Glaukos Corporation | $348.64 | 2022-2025 | Photrexa Viscous and Photrexa, Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Iaccess Precision Blade |
| Amgen INC. | $307.75 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $282.58 | 2023-2025 | Miebo, Prolensa, Lotemax Sm |
| Tarsus Pharmaceuticals, INC. | $192.74 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $173.34 | 2022-2025 | Tearcare System, Omni Surgical System |
| Horizon Therapeutics Plc | $170.19 | 2023 | Tepezza |
| Abbvie INC. | $160.42 | 2022-2024 | Alphagan P, Vuity, Lumigan |
| Oyster Point Pharma, INC. | $118.38 | 2023-2024 | Tyrvaya |
| Harrow Eye, LLC | $108.75 | 2023-2025 | Vevye, Iheezo |
| Rxsight INC | $73.86 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $53.25 | 2024 | Tecnis Iol, Tecnis Simplicity |
| Novartis Pharmaceuticals Corporation | $40.25 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $38.94 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $16.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Schmerbauch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.